Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Preventive Measures for Patients with an Elevated Genetic Risk for Gynecological Malignancies, in Particular Familial Breast and Ovarian Cancer.

Deutsches Arzteblatt international - 14 Nov 2025

Ditsch Nina, Aktas Bahriye, Banys-Paluchowski Maggie, Speiser Dorothee, Golas Monika M, Fasching Peter A

Abstract excerpt

BACKGROUND: Approximately 70 550 women receive a diagnosis of breast cancer in Germany each year. Ovarian cancer is much rarer, with approximately 7180 new cases per year. A woman's individual risk of breast and ovarian cancer can be quantitatively estimated with tools that are available online; these are playing an increasingly important role in genetic counseling. Environmental factors, lifestyles, and...

Read the complete abstract on PubMed

Topics

Female
Humans
Breast Neoplasms
Genetic Predisposition to Disease
Germany
Ovarian Neoplasms

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Primary Prevention

Risk Factors

Source

Open in PubMed Open full text

Identifiers

PMID: 41060639
DOI: 10.3238/arztebl.m2025.0173
PMCID: PMC13270979

Genes

BRCA1
BRCA2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 25 Oct 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Preventive Measures for Patients with an Elevated Genetic Risk for Gynecological Malignancies, in Particular Familial Breast and Ovarian Cancer.PMID 41060639Read ↗

[Clinical and familial characterisation of ovarian cancer patients with germline mutations in the BRCA1/2 gene and the current status of prevention in high-risk groups].Semantic proximity Read ↗

Breast Cancer Prevention in Patients with gBRCA-mutated Ovarian CancerSemantic proximity Read ↗

Hereditary gynecologic cancers: risk assessment, counseling, testing and management.Semantic proximity Read ↗

Clinical management recommendations for surveillance and risk-reduction strategies for hereditary breast and ovarian cancer among individuals carrying a deleterious BRCA1 or BRCA2 mutation.Semantic proximity Read ↗

Impact of non-BRCA genes in the indication of risk-reducing surgery in hereditary breast and ovarian cancer syndrome (HBOC).Semantic proximity Read ↗

Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: recommendation statement.Semantic proximity Read ↗

Breast and ovarian cancer genetics and prevention.Semantic proximity Read ↗

Risk-reducing mastectomy and salpingo-oophorectomy in women with hereditary breast and ovarian cancer: a single-institute experience following coverage by Japanese national medical insurance.Semantic proximity Read ↗

Fertility Counseling in BRCA1/2-Mutated Women with Breast Cancer and Healthy IndividualsSemantic proximity Read ↗

Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: U.S. Preventive Services Task Force recommendation statement.Semantic proximity Read ↗

Management Strategies of Breast Cancer Patients with BRCA1 and BRCA2 Pathogenic Germline VariantsSemantic proximity Read ↗

Genetic predisposition in gynecologic cancers: From knowledge to clinical management.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.